Orthofix Director Receives 18,841 Stock Units – Routine Compensation Grant
Orthofix Medical (NASDAQ:OFIX) filed a Form 4 disclosing that director Vickie L. Capps was granted 18,841 deferred stock units on 18 June 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Orthofix Medical (NASDAQ:OFIX) filed a Form 4 disclosing that director Vickie L. Capps was granted 18,841 deferred stock units on 18 June 2025. These units vest in full one year after the grant date, contingent upon continued board service, and will convert into common shares within 45 days of her separation from the company. Following the award, Capps’ reported beneficial ownership increased to 21,934 shares, which includes 3,093 previously disclosed units. The award carries no purchase price and no insider sales were reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 18,841 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
- F2. Includes 3,093 previously reported deferred stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Vickie L. Capps’ total beneficial ownership in OFIX after this award?
AI-generated analysis. How Rhea-AI works. Not financial advice.